Citi Starts Keryx Biopharmaceuticals (KERX) at Sell
Tweet
Share
E-mailGet Alerts KERX Hot Sheet
Price: $3.36 --0%
Rating Summary:
6 Buy, 10 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Rating Summary:
6 Buy, 10 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Join SI Premium – FREE
Citi initiated coverage on Keryx Biopharmaceuticals (NASDAQ: KERX) with a Sell rating and a price target of $1.50.
For an analyst ratings summary and ratings history on Keryx Biopharmaceuticals click here. For more ratings news on Keryx Biopharmaceuticals click here.
Shares of Keryx Biopharmaceuticals closed at $6.03 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Loop Capital Starts Instacart (CART) at Buy, 'Leading a Massive and Underpenetrated Category'
- Barclays Reinstates J D Wetherspoon PLC (JDW:LN) (JDWPF) at Overweight
- TD Cowen Resumes EQT Corp. (EQT) at Hold
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
